5 stocks to watch on Tuesday: Alphabet, Johnson & Johnson, Verizon and more
400tmax/iStock Unreleased via Getty Images


Stocks looked poised for a modest decline at the start of Tuesday's trading. A lower open would trim gains posted over the previous couple of days, as investors digest a new set of corporate earnings reports. Here are some stocks to watch on Tuesday:

Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) ticked lower in premarket trading amid reports that U.S. authorities could take further antitrust action against the Google parent. According to Bloomberg, the U.S. Justice Department is poised to file a suit against the company related to its position in the digital advertising market.
Johnson & Johnson (JNJ) reported a Q4 profit that beat analysts' expectations. Revenue came up short, falling 4% to $23.7B. This was $200M below projections, as COVID vaccine sales dropped and the healthcare giant faced unfavorable foreign currency exchange. Meanwhile, the company projected 2023 EPS of $10.45-$10.65, above the $10.33 that analysts were looking for.
Verizon (VZ) edged lower in premarket action following the release of its Q4 results. The company's profit matched analysts' estimates, while its revenue exceeded projections, rising almost 4% to $35.3B. For 2023, the telecom behemoth gave a disappointing forecast. The firm predicted adjusted EPS of $4.55-$4.85, below analysts' consensus of $4.97.
General Electric (GE) released a mixed earnings report, with a profit that came in above projections. Revenue rose 7% to $21.8B but missed estimates by $310M. The company reported strong demand for jet engines and power equipment.
Microsoft (MSFT) is scheduled to report its quarterly results after the closing bell. The software giant is projected to earn $2.31 per share on revenue of $53.2B. Investors will also be looking for updates on its cost-cutting program and its recently announced investment in ChatGPT developer OpenAI.


For more on the medium-term outlook for the market, see what CME Group identifies as the economic risks to watch out for in 2023.